United States · FDA National Drug Code directory
Hydromorphone Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 87063-038_451ccd08-4749-97a1-e063-6294a90ac5ad
- Product NDC
- 87063-038
- Form
- TABLET
- Composition / generic term
- Hydromorphone Hydrochloride
- Labeler
- ASCLEMED USA INC.
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start / end (source format)
- 20091123
- Source listing expiry
- 20261231
Source-listed ingredients
- HYDROMORPHONE HYDROCHLORIDE — 4 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE, PLASTIC (87063-038-01) · 87063-038-01
- 5 TABLET in 1 BOTTLE, PLASTIC (87063-038-05) · 87063-038-05
- 7 TABLET in 1 BOTTLE, PLASTIC (87063-038-07) · 87063-038-07
- 10 TABLET in 1 BOTTLE, PLASTIC (87063-038-10) · 87063-038-10
- 14 TABLET in 1 BOTTLE, PLASTIC (87063-038-14) · 87063-038-14
- 20 TABLET in 1 BOTTLE, PLASTIC (87063-038-20) · 87063-038-20
- 30 TABLET in 1 BOTTLE, PLASTIC (87063-038-30) · 87063-038-30
- 500 TABLET in 1 BOTTLE, PLASTIC (87063-038-50) · 87063-038-50
- 60 TABLET in 1 BOTTLE, PLASTIC (87063-038-60) · 87063-038-60
- 90 TABLET in 1 BOTTLE, PLASTIC (87063-038-90) · 87063-038-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →